Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China

• Автори: Pingjin Gao (Автор), Kezhi Mei (Автор), Hongwei Li (Автор), Qiuyan Dai (Автор), Xingui Guo (Автор), Daifu Zhang (Автор), Zhimin Jin (Автор), Hua You (Автор), Hong Ding (Автор), Ke Lü (Автор), Shuxian Zhou (Автор), Xiaoling Peng (Автор), Hui Xu (Автор), Pengfei Yin (Автор), Licheng Yu (Автор), Lin Pi (Автор), Qi Hua (Автор), Ming Yang (Автор), Xiaowei Yu (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2019-01-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Amlodipine (AML) is the initial therapy most commonly prescribed for patients with hypertension in China. However, AML monotherapy is often less effective in achieving blood pressure (BP) control than other agents. Objective: We performed a clinical study to evaluate efficacy and safety...